Richard Hunter
Tracked across 4 events · 39 articles · First seen May 12, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: As head of markets at Interactive Investor, Richard Hunter commented on WHSmith's capital raise, suggesting it could be a critical move for the company and would test investor patience.
Jun 10, 2026 · 7 articles
Business
Impact: Richard Hunter, head of markets at Interactive Investor, commented on Vodafone Idea's stock performance and investor sentiment.
May 12, 2026 · 6 articles
Business
AstraZeneca announced on August 17, 2026, that it is discontinuing the Phase III EVOLVE-Lung02 trial of volrustomig plus chemotherapy in patients with metastatic non-small cell lung cancer (mNSCLC). The decision followed a recommendation from an…
Impact: Richard Hunter, head of markets at interactive investor, commented on AstraZeneca's shares being higher despite the setback, highlighting the strength of its oncology pipeline.
Aug 17, 2026 · 20 articles
Business
Impact: Richard Hunter, head analyst at Interactive Investor, commented on Marks & Spencer's performance and investments despite the cyber attack.
May 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Richard Hunter live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard